Expansion of the clinical phenotype of GALE deficiency
暂无分享,去创建一个
A. Bertuch | F. Scaglia | D. Mahoney | S. Kirk | R. Markovitz | N. Owen | L. F. Satter
[1] T. Walsh,et al. Inherited thrombocytopenia associated with mutation of UDP‐galactose‐4‐epimerase (GALE) , 2018, Human molecular genetics.
[2] S. Rosenzweig,et al. Glycans Instructing Immunity: The Emerging Role of Altered Glycosylation in Clinical Immunology , 2015, Front. Pediatr..
[3] D. Timson,et al. Analysis of UDP-galactose 4′-epimerase mutations associated with the intermediate form of type III galactosaemia , 2008, Journal of Inherited Metabolic Disease.
[4] A. Cohen,et al. A clinical and molecular study of a Bedouin family with dysmegakaryopoiesis, mild anemia, and neutropenia cured by bone marrow transplantation , 2003, European journal of haematology.
[5] G. Matthijs,et al. Congenital disorders of glycosylation. , 2000, Trends in biochemical sciences.
[6] P. Rosoff. Myelodysplasia and deficiency of uridine diphosphate-galactose 4-epimerase. , 1995, The Journal of pediatrics.
[7] H. G. Eijk,et al. Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. , 1984, Clinica chimica acta; international journal of clinical chemistry.
[8] J. Fridovich-Keil,et al. Newborn screening for galactosemia in the United States: looking back, looking around, and looking ahead. , 2015, JIMD reports.
[9] M. Epstein,et al. Epimerase-deficiency galactosemia is not a binary condition. , 2006, American journal of human genetics.
[10] H. Schneiderman. First case. , 1987, The Western journal of medicine.